TETRAHYDRO-PYRIMIDOAZEPINES AS MODULATORS OF TRPV1
申请人:Janssen Pharmaceutica NV
公开号:US20140135311A1
公开(公告)日:2014-05-15
Certain tetrahydro-pyrimidoazepine compounds are described, which are useful as TRPV1 modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by TRPV1. Thus, the compounds may be administered to treat, e.g., pain, itch, cough, asthma, or inflammatory bowel disease.